Triggered Imaging in Glioblastoma Based on Clinical Outcome Evaluation Compared to Routine: a Feasibility Study
NCT07634575 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-06-09
Summary
This is a feasibility randomized controlled trial comparing triggered imaging based on patient symptom self-reporting and performance-based measures with the existing imaging schedule.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
triggered imaging
triggered imaging for symptoms as opposed to routine interval imaging
Sponsors & Collaborators
-
King's College Hospital NHS Trust
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
NCT05700955 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
NCT01345370 ·Status: COMPLETED
-
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
NCT00019578 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Radiation Therapy for Glioblastoma Multiforme
NCT01466686 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response
NCT07670455 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
NCT05739942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
NCT01019434 ·Status: COMPLETED ·Phase: PHASE2
-
Nimotuzumab in Adults With Glioblastoma Multiforma
NCT00753246 ·Status: COMPLETED ·Phase: PHASE3
-
NG101m Adjuvant Therapy in Glioblastoma Patients
NCT04373785 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
NCT04019262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
NCT00756106 ·Status: TERMINATED ·Phase: NA
-
FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
NCT06451042 ·Status: COMPLETED
-
Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
NCT01342757 ·Status: COMPLETED ·Phase: NA
-
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
NCT02709226 ·Status: COMPLETED ·Phase: PHASE1
-
UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
NCT04726397 ·Status: COMPLETED ·Phase: NA
-
A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma
NCT02805179 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
NCT00253448 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
NCT00190424 ·Status: COMPLETED ·Phase: PHASE2
-
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
NCT02329795 ·Status: TERMINATED
-
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
NCT05565326 ·Status: RECRUITING
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
NCT07343986 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
NCT07047066 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00053183 ·Status: COMPLETED ·Phase: PHASE1
-
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
NCT00027612 ·Status: COMPLETED ·Phase: PHASE1/PHASE2